Search

Scott David Priebe

Examiner (ID: 14721)

Most Active Art Unit
1632
Art Unit(s)
1633, 1819, 1805, 1632
Total Applications
686
Issued Applications
323
Pending Applications
150
Abandoned Applications
212

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4284372 [patent_doc_number] => RE037447 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Modified Kluyveromyces yeasts, their preparation and use' [patent_app_type] => 2 [patent_app_number] => 9/640305 [patent_app_country] => US [patent_app_date] => 2000-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 22 [patent_no_of_words] => 15876 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/037/RE037447.pdf [firstpage_image] =>[orig_patent_app_number] => 640305 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/640305
Modified Kluyveromyces yeasts, their preparation and use Aug 15, 2000 Issued
Array ( [id] => 1331742 [patent_doc_number] => 06596533 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Mutant having uracil phosphoribosyl transferase activity' [patent_app_type] => B1 [patent_app_number] => 09/446084 [patent_app_country] => US [patent_app_date] => 2000-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14620 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596533.pdf [firstpage_image] =>[orig_patent_app_number] => 09446084 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/446084
Mutant having uracil phosphoribosyl transferase activity Aug 13, 2000 Issued
09/632879 Growth differentiation factor promoter and uses therefor Aug 3, 2000 Abandoned
09/242951 SpoOJ2 of staphylococcus aureus Jul 27, 2000 Abandoned
Array ( [id] => 671995 [patent_doc_number] => 07091003 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-15 [patent_title] => 'Polypeptides having phospholipase B activity and nucleic acids encoding same' [patent_app_type] => utility [patent_app_number] => 09/615571 [patent_app_country] => US [patent_app_date] => 2000-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19506 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/091/07091003.pdf [firstpage_image] =>[orig_patent_app_number] => 09615571 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/615571
Polypeptides having phospholipase B activity and nucleic acids encoding same Jul 12, 2000 Issued
Array ( [id] => 1282713 [patent_doc_number] => 06638502 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors' [patent_app_type] => B1 [patent_app_number] => 09/403736 [patent_app_country] => US [patent_app_date] => 2000-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19994 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638502.pdf [firstpage_image] =>[orig_patent_app_number] => 09403736 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/403736
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors Jun 28, 2000 Issued
Array ( [id] => 7645762 [patent_doc_number] => 06472207 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Method for producing tagged genes, transcripts, and proteins' [patent_app_type] => B1 [patent_app_number] => 09/604037 [patent_app_country] => US [patent_app_date] => 2000-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 5130 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472207.pdf [firstpage_image] =>[orig_patent_app_number] => 09604037 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/604037
Method for producing tagged genes, transcripts, and proteins Jun 26, 2000 Issued
Array ( [id] => 1380778 [patent_doc_number] => 06551825 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'PiggyBac transposon-based genetic transformation system for insects' [patent_app_type] => B1 [patent_app_number] => 09/598421 [patent_app_country] => US [patent_app_date] => 2000-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 63 [patent_no_of_words] => 18583 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/551/06551825.pdf [firstpage_image] =>[orig_patent_app_number] => 09598421 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/598421
PiggyBac transposon-based genetic transformation system for insects Jun 18, 2000 Issued
Array ( [id] => 1516310 [patent_doc_number] => 06500432 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Method to enhance an immune response of nucleic acid vaccination' [patent_app_type] => B1 [patent_app_number] => 09/581368 [patent_app_country] => US [patent_app_date] => 2000-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8666 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500432.pdf [firstpage_image] =>[orig_patent_app_number] => 09581368 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/581368
Method to enhance an immune response of nucleic acid vaccination Jun 11, 2000 Issued
09/509937 SYNTHETIC GENES WITH IMMUNOMODULATORY EFFECTS Jun 8, 2000 Abandoned
Array ( [id] => 512004 [patent_doc_number] => 07196244 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-03-27 [patent_title] => 'Method of transposon-mediated mutagenesis in the nematode caenorhabditis elegans' [patent_app_type] => utility [patent_app_number] => 09/980644 [patent_app_country] => US [patent_app_date] => 2000-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 13330 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/196/07196244.pdf [firstpage_image] =>[orig_patent_app_number] => 09980644 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/980644
Method of transposon-mediated mutagenesis in the nematode caenorhabditis elegans May 31, 2000 Issued
Array ( [id] => 1391838 [patent_doc_number] => 06537540 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Methods and composition for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders' [patent_app_type] => B1 [patent_app_number] => 09/579845 [patent_app_country] => US [patent_app_date] => 2000-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 29 [patent_no_of_words] => 28897 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537540.pdf [firstpage_image] =>[orig_patent_app_number] => 09579845 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/579845
Methods and composition for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders May 25, 2000 Issued
Array ( [id] => 6473505 [patent_doc_number] => 20020151509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Adeno-associated viral vector-mediated delivery of DNA to cells of the liver' [patent_app_type] => new [patent_app_number] => 09/576858 [patent_app_country] => US [patent_app_date] => 2000-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13225 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151509.pdf [firstpage_image] =>[orig_patent_app_number] => 09576858 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/576858
Adeno-associated viral vector-mediated delivery of DNA to cells of the liver May 21, 2000 Issued
09/576081 Use of chimeric mutational vectors to change endogenous sequences in solid tissues May 19, 2000 Abandoned
Array ( [id] => 1091736 [patent_doc_number] => 06824771 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-30 [patent_title] => 'Infectivity-enhanced conditionally-replicative adenovirus and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/569789 [patent_app_country] => US [patent_app_date] => 2000-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 34 [patent_no_of_words] => 18431 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/824/06824771.pdf [firstpage_image] =>[orig_patent_app_number] => 09569789 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/569789
Infectivity-enhanced conditionally-replicative adenovirus and uses thereof May 11, 2000 Issued
Array ( [id] => 1073781 [patent_doc_number] => 06838446 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-04 [patent_title] => 'Vector for expression of GPI-enzyme hybrid' [patent_app_type] => utility [patent_app_number] => 09/959007 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 16671 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838446.pdf [firstpage_image] =>[orig_patent_app_number] => 09959007 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/959007
Vector for expression of GPI-enzyme hybrid Apr 27, 2000 Issued
Array ( [id] => 658316 [patent_doc_number] => 07105494 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-12 [patent_title] => 'Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies' [patent_app_type] => utility [patent_app_number] => 09/561524 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10624 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105494.pdf [firstpage_image] =>[orig_patent_app_number] => 09561524 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/561524
Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies Apr 27, 2000 Issued
Array ( [id] => 1516267 [patent_doc_number] => 06500419 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Method for introducing and expressing RNA in animal cells' [patent_app_type] => B1 [patent_app_number] => 09/545153 [patent_app_country] => US [patent_app_date] => 2000-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 26414 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500419.pdf [firstpage_image] =>[orig_patent_app_number] => 09545153 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/545153
Method for introducing and expressing RNA in animal cells Apr 6, 2000 Issued
Array ( [id] => 1514351 [patent_doc_number] => 06420161 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'dnaB from Staphylococcus aureus' [patent_app_type] => B1 [patent_app_number] => 09/543141 [patent_app_country] => US [patent_app_date] => 2000-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15897 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420161.pdf [firstpage_image] =>[orig_patent_app_number] => 09543141 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/543141
dnaB from Staphylococcus aureus Apr 4, 2000 Issued
09/526947 Enhanced Gamma-carboxylation of recombinant vitamin K-dependent clotting factors Mar 15, 2000 Abandoned
Menu